Selected research
Industry Research
Cat Medicines Industry Research Report 2026
Market perspective
The global Cat Medicines market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Cat Medicines is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Cat Medicines is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Cat Medicines is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Cat Medicines include Wuhan Chopperlvya Animal Health, Zoetis, Tianjin Ringpu Bio-technology, Nanjing Jindun Animal Pharmaceutical, Jining Wanhe Biotechnology (Belcol), Pfizer, Harbin Pharmaceutical Group, Taizhou Boleideli Biotechnology and Virbac, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Cat Medicines market in terms of revenue (US$ million) and, where applicable, sales volume (Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Cat Medicines Market by Company
Wuhan Chopperlvya Animal Health
Zoetis
Tianjin Ringpu Bio-technology
Nanjing Jindun Animal Pharmaceutical
Jining Wanhe Biotechnology (Belcol)
Pfizer
Harbin Pharmaceutical Group
Taizhou Boleideli Biotechnology
Virbac
Vetoquinol
Merck
IDEXX
Elanco
Dechra Veterinary Products
Ceva
Boehringer Ingelheim
Cat Medicines Segment by Type
Antiparasitic Drugs
Dermatological Drugs
Digestive System Drugs
Others
Cat Medicines Segment by Application
Online
Offline
Cat Medicines Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cat Medicines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cat Medicines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cat Medicines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Cat Medicines manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Cat Medicines by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Cat Medicines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Antiparasitic Drugs
- Dermatological Drugs
- Digestive System Drugs
- Others
Applications
- Online
- Offline
Companies covered
- Wuhan Chopperlvya Animal Health
- Zoetis
- Tianjin Ringpu Bio-technology
- Nanjing Jindun Animal Pharmaceutical
- Jining Wanhe Biotechnology (Belcol)
- Pfizer
- Harbin Pharmaceutical Group
- Taizhou Boleideli Biotechnology
- Virbac
- Vetoquinol
- Merck
- IDEXX
- Elanco
- Dechra Veterinary Products
- Ceva
- Boehringer Ingelheim
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Cat Medicines Market Size (2021-2032)
- 2.2.2 Global Cat Medicines Sales (2021-2032)
- 2.2.3 Global Cat Medicines Market Average Price (2021-2032)
- 2.3 Cat Medicines by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Antiparasitic Drugs
- 2.3.3 Dermatological Drugs
- 2.3.4 Digestive System Drugs
- 2.3.5 Others
- 2.4 Cat Medicines by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Online
- 2.4.3 Offline
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Cat Medicines Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Cat Medicines Sales (Tons) of Manufacturers (2021-2026)
- 3.3 Global Cat Medicines Revenue of Manufacturers (2021-2026)
- 3.4 Global Cat Medicines Average Price by Manufacturers (2021-2026)
- 3.5 Global Cat Medicines Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Cat Medicines, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Cat Medicines, Product Type & Application
- 3.8 Global Manufacturers of Cat Medicines, Established Date
- 3.9 Global Cat Medicines Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Wuhan Chopperlvya Animal Health
- 4.1.1 Wuhan Chopperlvya Animal Health Company Information
- 4.1.2 Wuhan Chopperlvya Animal Health Business Overview
- 4.1.3 Wuhan Chopperlvya Animal Health Cat Medicines Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Wuhan Chopperlvya Animal Health Cat Medicines Product Portfolio
- 4.1.5 Wuhan Chopperlvya Animal Health Recent Developments
- 4.2 Zoetis
- 4.2.1 Zoetis Company Information
- 4.2.2 Zoetis Business Overview
- 4.2.3 Zoetis Cat Medicines Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Zoetis Cat Medicines Product Portfolio
- 4.2.5 Zoetis Recent Developments
- 4.3 Tianjin Ringpu Bio-technology
- 4.3.1 Tianjin Ringpu Bio-technology Company Information
- 4.3.2 Tianjin Ringpu Bio-technology Business Overview
- 4.3.3 Tianjin Ringpu Bio-technology Cat Medicines Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Tianjin Ringpu Bio-technology Cat Medicines Product Portfolio
- 4.3.5 Tianjin Ringpu Bio-technology Recent Developments
- 4.4 Nanjing Jindun Animal Pharmaceutical
- 4.4.1 Nanjing Jindun Animal Pharmaceutical Company Information
- 4.4.2 Nanjing Jindun Animal Pharmaceutical Business Overview
- 4.4.3 Nanjing Jindun Animal Pharmaceutical Cat Medicines Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Nanjing Jindun Animal Pharmaceutical Cat Medicines Product Portfolio
- 4.4.5 Nanjing Jindun Animal Pharmaceutical Recent Developments
- 4.5 Jining Wanhe Biotechnology (Belcol)
- 4.5.1 Jining Wanhe Biotechnology (Belcol) Company Information
- 4.5.2 Jining Wanhe Biotechnology (Belcol) Business Overview
- 4.5.3 Jining Wanhe Biotechnology (Belcol) Cat Medicines Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Jining Wanhe Biotechnology (Belcol) Cat Medicines Product Portfolio
- 4.5.5 Jining Wanhe Biotechnology (Belcol) Recent Developments
- 4.6 Pfizer
- 4.6.1 Pfizer Company Information
- 4.6.2 Pfizer Business Overview
- 4.6.3 Pfizer Cat Medicines Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Pfizer Cat Medicines Product Portfolio
- 4.6.5 Pfizer Recent Developments
- 4.7 Harbin Pharmaceutical Group
- 4.7.1 Harbin Pharmaceutical Group Company Information
- 4.7.2 Harbin Pharmaceutical Group Business Overview
- 4.7.3 Harbin Pharmaceutical Group Cat Medicines Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Harbin Pharmaceutical Group Cat Medicines Product Portfolio
- 4.7.5 Harbin Pharmaceutical Group Recent Developments
- 4.8 Taizhou Boleideli Biotechnology
- 4.8.1 Taizhou Boleideli Biotechnology Company Information
- 4.8.2 Taizhou Boleideli Biotechnology Business Overview
- 4.8.3 Taizhou Boleideli Biotechnology Cat Medicines Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Taizhou Boleideli Biotechnology Cat Medicines Product Portfolio
- 4.8.5 Taizhou Boleideli Biotechnology Recent Developments
- 4.9 Virbac
- 4.9.1 Virbac Company Information
- 4.9.2 Virbac Business Overview
- 4.9.3 Virbac Cat Medicines Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Virbac Cat Medicines Product Portfolio
- 4.9.5 Virbac Recent Developments
- 4.10 Vetoquinol
- 4.10.1 Vetoquinol Company Information
- 4.10.2 Vetoquinol Business Overview
- 4.10.3 Vetoquinol Cat Medicines Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Vetoquinol Cat Medicines Product Portfolio
- 4.10.5 Vetoquinol Recent Developments
- 4.11 Merck
- 4.11.1 Merck Company Information
- 4.11.2 Merck Business Overview
- 4.11.3 Merck Cat Medicines Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Merck Cat Medicines Product Portfolio
- 4.11.5 Merck Recent Developments
- 4.12 IDEXX
- 4.12.1 IDEXX Company Information
- 4.12.2 IDEXX Business Overview
- 4.12.3 IDEXX Cat Medicines Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 IDEXX Cat Medicines Product Portfolio
- 4.12.5 IDEXX Recent Developments
- 4.13 Elanco
- 4.13.1 Elanco Company Information
- 4.13.2 Elanco Business Overview
- 4.13.3 Elanco Cat Medicines Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Elanco Cat Medicines Product Portfolio
- 4.13.5 Elanco Recent Developments
- 4.14 Dechra Veterinary Products
- 4.14.1 Dechra Veterinary Products Company Information
- 4.14.2 Dechra Veterinary Products Business Overview
- 4.14.3 Dechra Veterinary Products Cat Medicines Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Dechra Veterinary Products Cat Medicines Product Portfolio
- 4.14.5 Dechra Veterinary Products Recent Developments
- 4.15 Ceva
- 4.15.1 Ceva Company Information
- 4.15.2 Ceva Business Overview
- 4.15.3 Ceva Cat Medicines Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Ceva Cat Medicines Product Portfolio
- 4.15.5 Ceva Recent Developments
- 4.16 Boehringer Ingelheim
- 4.16.1 Boehringer Ingelheim Company Information
- 4.16.2 Boehringer Ingelheim Business Overview
- 4.16.3 Boehringer Ingelheim Cat Medicines Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Boehringer Ingelheim Cat Medicines Product Portfolio
- 4.16.5 Boehringer Ingelheim Recent Developments
5 Global Cat Medicines Market Scenario by Region
- 5.1 Global Cat Medicines Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Cat Medicines Sales by Region: 2021-2032
- 5.2.1 Global Cat Medicines Sales by Region: 2021-2026
- 5.2.2 Global Cat Medicines Sales by Region: 2027-2032
- 5.3 Global Cat Medicines Revenue by Region: 2021-2032
- 5.3.1 Global Cat Medicines Revenue by Region: 2021-2026
- 5.3.2 Global Cat Medicines Revenue by Region: 2027-2032
- 5.4 North America Cat Medicines Market Facts & Figures by Country
- 5.4.1 North America Cat Medicines Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Cat Medicines Sales by Country (2021-2032)
- 5.4.3 North America Cat Medicines Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Cat Medicines Market Facts & Figures by Country
- 5.5.1 Europe Cat Medicines Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Cat Medicines Sales by Country (2021-2032)
- 5.5.3 Europe Cat Medicines Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Cat Medicines Market Facts & Figures by Country
- 5.6.1 Asia Pacific Cat Medicines Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Cat Medicines Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Cat Medicines Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Cat Medicines Market Facts & Figures by Country
- 5.7.1 South America Cat Medicines Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Cat Medicines Sales by Country (2021-2032)
- 5.7.3 South America Cat Medicines Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Cat Medicines Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Cat Medicines Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Cat Medicines Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Cat Medicines Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Cat Medicines Sales by Type (2021-2032)
- 6.1.1 Global Cat Medicines Sales by Type (2021-2032) & (Tons)
- 6.1.2 Global Cat Medicines Sales Market Share by Type (2021-2032)
- 6.2 Global Cat Medicines Revenue by Type (2021-2032)
- 6.2.1 Global Cat Medicines Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Cat Medicines Revenue Market Share by Type (2021-2032)
- 6.3 Global Cat Medicines Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Cat Medicines Sales by Application (2021-2032)
- 7.1.1 Global Cat Medicines Sales by Application (2021-2032) & (Tons)
- 7.1.2 Global Cat Medicines Sales Market Share by Application (2021-2032)
- 7.2 Global Cat Medicines Revenue by Application (2021-2032)
- 7.2.1 Global Cat Medicines Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Cat Medicines Revenue Market Share by Application (2021-2032)
- 7.3 Global Cat Medicines Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Cat Medicines Value Chain Analysis
- 8.1.1 Cat Medicines Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Cat Medicines Production Mode & Process
- 8.2 Cat Medicines Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Cat Medicines Distributors
- 8.2.3 Cat Medicines Customers
9 Global Cat Medicines Analyzing Market Dynamics
- 9.1 Cat Medicines Industry Trends
- 9.2 Cat Medicines Industry Drivers
- 9.3 Cat Medicines Industry Opportunities and Challenges
- 9.4 Cat Medicines Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst